Navigation Links
FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy
Date:4/6/2009

The nation’s most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals announces exclusive sanofi pasteur Fluzone® agreement for select GPOs, as well as new Fluzone® return policy.

(Vocus) April 6, 2009 -- As a trusted partner in the flu vaccine distribution marketplace, FFF Enterprises, Inc., is pleased to announce that sanofi pasteur has named FFF the exclusive Fluzone® distributor for the following GPO contracts: Amerinet, Broadlane, HealthTrust, MedAssets, MHA, Novation and Premier. “Sanofi pasteur is a longtime valued manufacturing partner, and we are honored to be its exclusive distributor of Fluzone® for these GPO contracts,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc.

In addition, FFF announced it is now offering lowered pricing for Fluzone®, and has introduced a return guarantee for this product. Under the new Fluzone® return policy, customers may return up to 25 percent of full, unopened vials or boxes of Fluzone purchased from FFF for a full refund. “We have a legacy of providing solutions that mitigate and/or remove risks for our customers, and the new Fluzone® return policy helps healthcare workers on the front line prepare for flu season without the risk of holding leftover inventory at the end of the season,” continues Schmidt.

It is this kind of commitment to what the company calls “Wow! Customer Care!” that has made FFF a respected industry leader for over 21 years. FFF has dedicated more than two decades to building collaborative relationships with its GPO partners to assure a mutual benefit from FFF’s extensive marketplace reach, fair pricing and availability of product. The announcement of these exclusive contracts demonstrates the quality of the relationships FFF has established with its manufacturing partners.

Customers can order their Fluzone® online at MyFluVaccine.com or by phone or fax, with the confidence of knowing their vaccine will arrive on time, and that they will not have to worry about excess inventory.

About FFF Enterprises, Inc.

FFF Enterprises, Inc., a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 21st year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF’s MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

# # #

Read the full story at http://www.prweb.com/releases/2009/04/prweb2298094.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. James M. Sweeney Named Chairman and CEO of IntelliDOT
2. KGBTexas Named Public Relations Agency of Record for PurinaCare(R) Pet Health Insurance
3. NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters
4. iVisit Named Finalist in CTIA Wireless 2009(R) CTIA E-Tech Awards for Innovation in Enterprise & Vertical - Healthcare Solution
5. Central DuPage Hospital Named a 100 Top Hospital in the U.S. for Third Consecutive Year
6. Dr Howard Holtz Named New Jersey Top Doctor for Third Consecutive Year
7. 2 NYU scientists named Howard Hughes Medical Institutes Early Career Scientists
8. Three New Trustees Named By March of Dimes Foundation
9. Two NYU Scientists Named Howard Hughes Medical Institutes early career scientists
10. QHR Management Client Hancock Medical Center Named Mississippi Hospital of the Year
11. Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy
(Date:2/5/2016)... ... 05, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Tasting Event at the La Gorce Country Club in Miami Beach on March ...
(Date:2/5/2016)... ... 2016 , ... Regular gym users know the routine: each January, they see ... the treadmills. It’s a predictable trend. After the excesses of November and December, people ... by joining gyms, starting new walking or running routines, or signing up for Zumba. ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... (APDA) announced the election of Patrick McDermott as Chairman of the National Board of ... welcome Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... ... Move from on one drop zone to the next using Colorize's dynamic moving camera. ... any project. This package includes a 3D slideshow environment with 1 to 5 focus ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... for Patients with Rare Diseases, a continuing medical education (CME) event presented by ... first of its kind—and a first for ACCORD, whose mission is to provide ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Summary ... common cancer and the most common cancer in women ... the disease exceedingly prevalent. The number of women diagnosed ... decades, but the number of deaths has declined due ... cancer treatment has been revolutionized in the past four ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
Breaking Medicine Technology: